EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA

Clinical trials for EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Experimental triple therapy targets tough lung cancer

Disease control Ongoing

This early-phase trial tests a three-drug combination (tazemetostat, topotecan, and pembrolizumab) in adults whose small cell lung cancer has returned after prior treatment. The goal is to find the safest dose and see if the combo can shrink or stabilize the cancer. About 18 part…

Matched conditions: EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 01, 2026 15:56 UTC

EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA

Get alerted when new EXTENSIVE STAGE LUNG SMALL CELL CARCINOMA trials appear

Experimental triple therapy targets tough lung cancer